- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 25.11. | CH BIOTECH SER (08037): VOLUNTARY ANNOUNCEMENT - THE BNCT DEVICE SUCCESSFULLY PERFORMED ITS FIRST BEAM EMISSION | - | HKEx | ||
| 31.10. | CH BIOTECH SER (08037): EXTENSION OF LONG STOP DATE REGARDING EXEMPTED CONNECTED TRANSACTION IN RELATION TO THE ADOPTION OF SHARE AWARD SCHEME BY AND ... | - | HKEx | ||
| CHINA BIOTECH SERVICES Aktie jetzt für 0€ handeln | |||||
| 22.10. | CH BIOTECH SER (08037): QUARTERLY UPDATE ON IMPLEMENTATION OF ACTION PLAN TO RESOLVE DISCLAIMER OF OPINION | - | HKEx | ||
| 29.09. | CH BIOTECH SER (08037): ALTERATIONS IN TERMS OF CONVERTIBLE BONDS IN RELATION TO ADDITIONAL GUARANTEES | - | HKEx | ||
| 26.09. | CH BIOTECH SER (08037): NOTIFICATION LETTER TO NON-REGISTERED SHAREHOLDERS | - | HKEx | ||
| 26.09. | CH BIOTECH SER (08037): NOTIFICATION LETTER TO REGISTERED SHAREHOLDERS AND REPLY FORM | - | HKEx | ||
| 26.09. | CH BIOTECH SER (08037): INTERIM REPORT 2025 | - | HKEx | ||
| 11.09. | CH BIOTECH SER (08037): VOLUNTARY ANNOUNCEMENT - GRANTING OF A LOAN BY A BANK TO A SUBSIDIARY OF THE COMPANY | 2 | HKEx | ||
| 08.09. | CH BIOTECH SER (08037): SUPPLEMENTAL ANNOUNCEMENT - DISCLOSEABLE TRANSACTION INVESTMENT IN A SUBSIDIARY OF THE COMPANY BY AN INVESTOR | 1 | HKEx | ||
| 27.08. | CH BIOTECH SER (08037): ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2025 | - | HKEx | ||
| 15.08. | CH BIOTECH SER (08037): NOTICE OF BOARD MEETING | - | HKEx | ||
| 08.08. | CH BIOTECH SER (08037): PROFIT ALERT - REDUCTION IN LOSS | - | HKEx | ||
| 25.07. | CH BIOTECH SER (08037): COMPANY INFORMATION SHEET | 1 | HKEx | ||
| 25.07. | CH BIOTECH SER (08037): LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION | 1 | HKEx | ||
| 25.07. | CH BIOTECH SER (08037): APPOINTMENT OF EXECUTIVE DIRECTOR; RESIGNATION AND APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTORS; CHANGES IN COMPOSITION ... | 1 | HKEx | ||
| 22.07. | CH BIOTECH SER (08037): QUARTERLY UPDATE ON IMPLEMENTATION OF ACTION PLAN TO RESOLVE DISCLAIMER OF OPINION | - | HKEx | ||
| 11.07. | CH BIOTECH SER (08037): VOLUNTARY ANNOUNCEMENT - MEMORANDUM OF UNDERSTANDING IN RELATION TO COOPERATION ON BNCT MEDICAL INSURANCE PRODUCT | 2 | HKEx | ||
| 30.06. | CH BIOTECH SER (08037): TERMS OF REFERENCE OF THE NOMINATION COMMITTEE | - | HKEx |
18 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| DEXCOM | 56,11 | +0,16 % | Here's Why You Should Hold DexCom Stock in Your Portfolio for Now | ||
| MCKESSON | 691,40 | +0,58 % | If You Invested $100 In McKesson Stock 20 Years Ago, You Would Have This Much Today | ||
| MOUNTAIN VALLEY MD | 0,009 | 0,00 % | Mountain Valley MD Holdings Inc: Mountain Valley appoints Batchelor as director | ||
| MEDLINE | 40,450 | 0,00 % | Aktien New York: Nasdaq schwach nach starkem Jahr - Medline-Börsengang im Blick | NEW YORK (dpa-AFX) - Die US-Börsen haben am Mittwoch erneut nachgegeben. Die Wall Street und vor allem die technologielastige Nasdaq zollten ihrem starken Lauf im Jahr 2025 weiter Tribut. Sorgen über... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 35,590 | 0,00 % | BrightSpring upgraded at KeyBanc on specialty pharmacy and EBITDA prospects | ||
| HEARTBEAM | 3,060 | 0,00 % | Heartbeam stock is a buy, this analyst says | ||
| PROGYNY | 26,010 | 0,00 % | Progyny, Inc. - 8-K, Current Report | ||
| ALIGNMENT HEALTHCARE | 20,550 | 0,00 % | Alignment Healthcare Reports Third Quarter 2025 Results, Surpasses High-End of Guidance Across All Key Metrics | Reports Q3 revenue of $993.7 million, up 43.5% year-over-yearBeats high end of third quarter guidance and raises full-year outlook across all key metrics: membership, revenue, adjusted gross profit... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 44,510 | -0,29 % | BERNSTEIN RESEARCH stuft Siemens Healthineers auf 'Outperform' | NEW YORK (dpa-AFX Analyser) - Das US-Analysehaus Bernstein Research hat Siemens Healthineers mit "Outperform" und einem Kursziel von 52,90 Euro in die Bewertung wieder aufgenommen. Nach einem für die... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,200 | -0,25 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| BETA BIONICS | 29,200 | 0,00 % | Beta Bionics, Inc.: Beta Bionics Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Guidance | IRVINE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| FRESENIUS | 47,860 | +0,17 % | JPMORGAN stuft Fresenius SE auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Fresenius mit einem Kursziel von 53,60 Euro auf "Overweight" belassen. Die Veranstaltung mit dem Biopharma-Management der Bad... ► Artikel lesen | |
| GENEDX | 135,46 | 0,00 % | GeneDx and Guardant Health named as BTIG's top picks for 2026 | ||
| PROCEPT BIOROBOTICS | 33,780 | 0,00 % | UBS stuft Procept BioRobotics mit "Buy" ein - Wachstum bei Systemauslastung als Treiber | ||
| RXSIGHT | 12,620 | 0,00 % | Pre-market Movers: Basel Medical Group, SOBR Safe, ProKidney, RxSight, Mustang Bio | OTTAWA (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 08.05 A.M. ET).In the Green Basel Medical Group Ltd (BMGL) is up over 88% at... ► Artikel lesen |
CHINA BIOTECH SERVICES HOLDINGS LTD gehört der Branche Gesundheitswesen an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CHINA BIOTECH SERVICES HOLDINGS LTD finden Sie auf Wallstreet Online.